HKG:2160

1 story mentioning HKG:2160Updated 1h ago

Every FINWIRES story that references HKG:2160, newest first.

MicroPort CardioFlow Sees Net Loss of Up to $25 Million in H1

MicroPort CardioFlow Medtech (HKG:2160) expects to record a net loss of no more than $25 million for the first half of 2026, according to a Tuesday filing with the Hong Kong Stock Exchange.The company also expects to post revenue of not less than $153 million for the period.

HKG:2160

Track with the FINWIRES app suite

FolioX

Track HKG:2160 in your portfolio

WheelAI

Analyze HKG:2160 options with the wheel strategy

StockInsider

See market sentiment on HKG:2160